PDE4A and lung adenocarcinoma: The inhibitory effect of cAMP on mTOR can be also neutralized by phosphodiesterase 4 (PDE4), an enzyme in which two of four isoforms (PDE4A and PDE4D) are increased under hypoxia in lung adenocarcinoma cell lines (Fig. 1)13, 14.